Clinical Trials Logo

Insulin Resistance clinical trials

View clinical trials related to Insulin Resistance.

Filter by:

NCT ID: NCT04623320 Recruiting - Type 1 Diabetes Clinical Trials

Validation of a 13C Glucose Breath Test Compared With the Euglycaemic Clamp Test

BRECLAIR
Start date: October 27, 2020
Phase:
Study type: Observational [Patient Registry]

Insulin resistance can be assessed by the euglycaemic clamp technique. To date, this is the golden standard, but it is not suited for clinical practice. A 13C glucose breath test will be tested as a valid alternative. The curve of the exhaled 13C CO2 as a function of glucose metabolism can be correlated to the curve of the glucose disposal rate obtained via the clamp technique.

NCT ID: NCT04622683 Recruiting - Healthy Clinical Trials

Effects of Hepatic Ultrasound on Metabolic Homeostasis

Start date: January 1, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to define the effect of ultrasound exposure of the liver in the region of the porta hepatis on glucose homeostasis and insulin resistance in healthy subjects.

NCT ID: NCT04617405 Recruiting - Clinical trials for Diabetes Mellitus, Type 2

Hormonal and Inflammatory Changes During Pregnancy in Women With Glucose Metabolic Disorders.

HI-MET
Start date: January 11, 2021
Phase:
Study type: Observational

The first aim of this study is to describe maternal hormonal and inflammatory changes during pregnancy in women that differ metabolically (limited to women with type 2 diabetes, gestational diabetes and/or overweight). The second aim of this study is to examine maternal hormonal, inflammatory and metabolic factors associated with insulin sensitivity in human pregnancy.

NCT ID: NCT04596592 Recruiting - Insulin Sensitivity Clinical Trials

Pubertal Blockade and Estradiol Effects on Cardiometabolic Health for Transitioning Youth

PUBERTY
Start date: February 15, 2021
Phase:
Study type: Observational

To evaluate the effect of estradiol with or without a prior gonadotropin releasing hormone analogue on insulin sensitivity and vascular function in transgender females compared to cisgender controls.

NCT ID: NCT04581980 Recruiting - Obesity Clinical Trials

Effects of Obesity and Intensity of Exercise on Ghrelin Levels

Start date: October 14, 2020
Phase: N/A
Study type: Interventional

This study is investigating the effect of different intensities of exercise on levels of the hormone, ghrelin. In addition, we will be examining the relationship between any exercise induced changes in ghrelin and insulin sensitivity, obesity, and vascular function.

NCT ID: NCT04578652 Recruiting - Insulin Resistance Clinical Trials

Fiber and Metformin Combination Therapy in Adolescents With Severe Obesity and Insulin Resistance

Start date: October 22, 2021
Phase: Phase 3
Study type: Interventional

This is a 12-month, single center, three-arm parallel design, double-blind, randomized clinical trial, to compare the effects of supplemental dietary fiber and metformin (MET) alone and in combination over 12 months on glucose metabolism (insulin resistance [IR]), inflammation and BMI in adolescents with obesity and IR, and to assess the relationship between therapeutic intervention(s) and changes in gut microbiome composition and function. Since MET and FIBER have been shown to reduce weight and increase insulin sensitivity through distinct but overlapping mechanisms of action, our central hypothesis is that the combination of FIBER + MET will have a synergistic effect and be more effective than FIBER or MET alone in improving metabolic function (IR) and reducing BMI and inflammation in adolescents with obesity, IR and family history (FM) of T2DM. .

NCT ID: NCT04547426 Recruiting - Insulin Sensitivity Clinical Trials

Effects of Snuff and/or Red Wine om Metabolic Rate

Start date: August 31, 2020
Phase: N/A
Study type: Interventional

About 14 healthy participants, consume a standardized breakfast combined with either using regular or nicotine-free moist snuff. The metabolic rate is measured every hour for four hours on each occasion starting in the morning. Participants are also randomized to get red wine or non-alcoholic red wine to the meal.

NCT ID: NCT04485871 Recruiting - Type 2 Diabetes Clinical Trials

Targeting Risk Factors for Diabetes in Subjects With Normal Blood Cholesterol Using Omega-3 Fatty Acids

Start date: December 19, 2019
Phase: N/A
Study type: Interventional

Every 3 minutes a new case of diabetes is diagnosed in Canada, mostly type 2 diabetes (T2D) increasing the risk for heart disease. T2D and heart disease share many common risk factors such as aging, obesity and unhealthy lifestyle. Paradoxically however, while lowering blood LDL, commonly known as "bad cholesterol", is protective against heart disease, research over the past 10 years have shown that the lower is blood LDL, the higher is the chance of developing T2D. This phenomena is happening whether blood LDL is lowered by a common drug against heart disease called Statins, or by being born with certain variations in genes, some of which are very common (~80% of people have them). To date, it is unclear why lowering blood LDL is associated with higher risk for diabetes, and whether this can be treated naturally with certain nutrients. Investigators believe that lowering blood LDL by forcing LDL entry into the body tissue through their receptors promotes T2D. This is because investigators have shown that LDL entry into human fat tissue induces fat tissue dysfunction, which would promote T2D especially in subjects with excess weight. On the other hand, investigators have shown that omega-3 fatty acids (omega-3) can directly treat the same defects induced by LDL entry into fat tissue. Omega-3 is a unique type of fat that is found mostly in fish oil. Thus the objectives of this clinical trial to be conducted in 48 subjects with normal blood LDL are to explore if: 1. Subjects with higher LDL receptors and LDL entry into fat tissue have higher risk factors for T2D compared to subjects with lower LDL receptors and LDL entry into fat tissue 2. 6-month supplementation of omega-3 from fish oil can treat subjects with higher LDL receptors and LDL entry into fat tissue reducing their risk for T2D. This study will thus explore and attempt to treat a new risk factor for T2D using an inexpensive and widely accessible nutraceutical, which would aid in preventing T2D in humans.

NCT ID: NCT04482374 Recruiting - Clinical trials for Endothelial Dysfunction

Puberty Suppression and Cardiometabolic Health

Start date: August 10, 2020
Phase:
Study type: Observational

This observational study will evaluate the effect of puberty suppression on insulin sensitivity, metabolic rate and vascular health among transgender female youth at baseline and 6 months after initiation of a gondoatropin releasing hormone agonist compared to matched cisgender male controls.

NCT ID: NCT04476160 Recruiting - Insulin Resistance Clinical Trials

Effectiveness of Cinnamon on Insulin Resistance ( ECIRCCOS ) December 1, 2019

ECIRCCOS
Start date: November 12, 2019
Phase: N/A
Study type: Interventional

Childhood obesity is one of the most serious public health problems of the 21st century. It is considered that if there are no changes in prevention and treatment strategies there will be an increase to 70 million obese children by 2025. Of the only pharmacological treatments accepted at this age to improve insulin resistance is metformin, but it can condition gastrointestinal, muscular and hepatic adverse events. Cinnamon is an alternative therapy, which due to its high concentrations of polyphenols, improves insulin resistance by decreasing the proinflammatory environment that occurs in this group of patients, and unlike metformin with less frequent adverse events. The effectiveness of cinnamon has been demonstrated by decreasing insulin resistance in the adult population.